Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2004 2
2005 3
2006 4
2007 4
2008 2
2009 1
2010 4
2011 1
2012 1
2013 1
2014 1
2015 4
2016 1
2017 4
2018 2
2019 1
2020 3
2021 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Results by year

Filters applied: . Clear all
Page 1
8th edition of the AJCC/TNM staging system of thyroid cancer: what to expect (ITCO#2).
Lamartina L, Grani G, Arvat E, Nervo A, Zatelli MC, Rossi R, Puxeddu E, Morelli S, Torlontano M, Massa M, Bellantone R, Pontecorvi A, Montesano T, Pagano L, Daniele L, Fugazzola L, Ceresini G, Bruno R, Rossetto R, Tumino S, Centanni M, Meringolo D, Castagna MG, Salvatore D, Nicolucci A, Lucisano G, Filetti S, Durante C. Lamartina L, et al. Among authors: torlontano m. Endocr Relat Cancer. 2018 Mar;25(3):L7-L11. doi: 10.1530/ERC-17-0453. Epub 2017 Nov 30. Endocr Relat Cancer. 2018. PMID: 29192093 Free article. No abstract available.
Nonsurgical approaches to the management of thyroid nodules.
Filetti S, Durante C, Torlontano M. Filetti S, et al. Among authors: torlontano m. Nat Clin Pract Endocrinol Metab. 2006 Jul;2(7):384-94. doi: 10.1038/ncpendmet0215. Nat Clin Pract Endocrinol Metab. 2006. PMID: 16932321 Review.
TERT Promoter Mutations in Papillary Thyroid Microcarcinomas.
de Biase D, Gandolfi G, Ragazzi M, Eszlinger M, Sancisi V, Gugnoni M, Visani M, Pession A, Casadei G, Durante C, Costante G, Bruno R, Torlontano M, Paschke R, Filetti S, Piana S, Frasoldati A, Tallini G, Ciarrocchi A. de Biase D, et al. Among authors: torlontano m. Thyroid. 2015 Sep;25(9):1013-9. doi: 10.1089/thy.2015.0101. Epub 2015 Aug 5. Thyroid. 2015. PMID: 26148423
The natural history of benign thyroid nodules.
Durante C, Costante G, Lucisano G, Bruno R, Meringolo D, Paciaroni A, Puxeddu E, Torlontano M, Tumino S, Attard M, Lamartina L, Nicolucci A, Filetti S. Durante C, et al. Among authors: torlontano m. JAMA. 2015 Mar 3;313(9):926-35. doi: 10.1001/jama.2015.0956. JAMA. 2015. PMID: 25734734
Mitotane Concentrations Influence Outcome in Patients with Advanced Adrenocortical Carcinoma.
Puglisi S, Calabrese A, Basile V, Ceccato F, Scaroni C, Altieri B, Della Casa S, Loli P, Pivonello R, De Martino MC, Canu L, Russo M, Badalamenti G, Torlontano M, Stigliano A, Ferraù F, Arnaldi G, Saba L, Quirino A, Perotti P, Berchialla P, Terzolo M. Puglisi S, et al. Among authors: torlontano m. Cancers (Basel). 2020 Mar 20;12(3):740. doi: 10.3390/cancers12030740. Cancers (Basel). 2020. PMID: 32245135 Free PMC article.
Minimal Extrathyroidal Extension in Predicting 1-Year Outcomes: A Longitudinal Multicenter Study of Low-to-Intermediate-Risk Papillary Thyroid Carcinoma (ITCO#4).
Forleo R, Grani G, Alfò M, Zilioli V, Giubbini R, Zatelli MC, Gagliardi I, Piovesan A, Ragni A, Morelli S, Puxeddu E, Pagano L, Deandrea M, Ceresini G, Torlontano M, Puligheddu B, Antonelli A, Centanni M, Fugazzola L, Spiazzi G, Monti S, Rossetto R, Monzani F, Tallini G, Crescenzi A, Sparano C, Bruno R, Repaci A, Tumino D, Pezzullo L, Lombardi CP, Ferraro Petrillo U, Filetti S, Durante C, Castagna MG. Forleo R, et al. Among authors: torlontano m. Thyroid. 2021 Dec;31(12):1814-1821. doi: 10.1089/thy.2021.0248. Epub 2021 Oct 20. Thyroid. 2021. PMID: 34541894
Mitotane Concentrations Influence the Risk of Recurrence in Adrenocortical Carcinoma Patients on Adjuvant Treatment.
Puglisi S, Calabrese A, Basile V, Ceccato F, Scaroni C, Simeoli C, Torlontano M, Cannavò S, Arnaldi G, Stigliano A, Malandrino P, Saba L, Altieri B, Della Casa S, Perotti P, Berchialla P, De Filpo G, Canu L, Loli P, Reimondo G, Terzolo M. Puglisi S, et al. Among authors: torlontano m. J Clin Med. 2019 Nov 2;8(11):1850. doi: 10.3390/jcm8111850. J Clin Med. 2019. PMID: 31684071 Free PMC article.
Real-World Performance of the American Thyroid Association Risk Estimates in Predicting 1-Year Differentiated Thyroid Cancer Outcomes: A Prospective Multicenter Study of 2000 Patients.
Grani G, Zatelli MC, Alfò M, Montesano T, Torlontano M, Morelli S, Deandrea M, Antonelli A, Francese C, Ceresini G, Orlandi F, Maniglia CA, Bruno R, Monti S, Santaguida MG, Repaci A, Tallini G, Fugazzola L, Monzani F, Giubbini R, Rossetto R, Mian C, Crescenzi A, Tumino D, Pagano L, Pezzullo L, Lombardi CP, Arvat E, Petrone L, Castagna MG, Spiazzi G, Salvatore D, Meringolo D, Solaroli E, Monari F, Magri F, Triggiani V, Castello R, Piazza C, Rossi R, Ferraro Petrillo U, Filetti S, Durante C. Grani G, et al. Among authors: torlontano m. Thyroid. 2021 Feb;31(2):264-271. doi: 10.1089/thy.2020.0272. Epub 2020 Jul 1. Thyroid. 2021. PMID: 32475305
Safety and Quality-of-Life Data from an Italian Expanded Access Program of Lenvatinib for Treatment of Thyroid Cancer.
Giani C, Valerio L, Bongiovanni A, Durante C, Grani G, Ibrahim T, Mariotti S, Massa M, Pani F, Pellegriti G, Porcelli T, Salvatore D, Tavarelli M, Torlontano M, Locati L, Molinaro E, Elisei R. Giani C, et al. Among authors: torlontano m. Thyroid. 2021 Feb;31(2):224-232. doi: 10.1089/thy.2020.0276. Epub 2020 Oct 22. Thyroid. 2021. PMID: 32907501
35 results